US Stock MarketDetailed Quotes

CTMX CytomX

Watchlist
  • 0.677
  • +0.002+0.30%
Close Feb 28 16:00 ET
  • 0.690
  • +0.013+1.89%
Post 18:44 ET
53.00MMarket Cap4.23P/E (TTM)

CytomX Key Stats

CytomX Q4 2024 Estimates Date

Currency:USDMar 6, 2025

Estimate YoY
Revenue
13.53M
-49.14%
EPS
-0.20
-2123.00%
Strong Buy

Feb 28, 2025

CytomX Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.500M--
Mar 6, 20252024/Q4-- / 13.533M--
Nov 7, 20242024/Q333.432M / 17.100M--
Aug 8, 20242024/Q225.115M / 19.994M--
May 8, 20242024/Q141.463M / 21.721M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.500M--
Mar 6, 20252024/Q4-- / 13.533M--
Nov 7, 20242024/Q333.432M / 17.100M--
Aug 8, 20242024/Q225.115M / 19.994M--
May 8, 20242024/Q141.463M / 21.721M--

Unlock Free Earnings Estimates

CytomX Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Strong Buy

  • Buy

    80.00%
  • Hold

    20.00%
  • Sell

    0.00%

Price Target

No Data